Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will have modified hours during the holiday season.

  • Closing early at 12:00pm on December 31, 2025
  • Closed on January 1, 2026


Have a healthy, happy holiday!

Hide
Quest Diagnostics

A Systematic Analysis of the Clinical Outcome Associated With Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients

A Systematic Analysis of the Clinical Outcome Associated With Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients

Authors: Nagyova E, Hoorntje ET, Rijdt WPT, Bosman LP, Syrris P, Protonotarios A, Elliott PM, Tsatsopoulou A, Mestroni L, Taylor MRG, Sinagra G, Merlo M, Wada Y, Horie M, Mogensen J, Christensen AH, Gerull B, Song L, Yao Y, Fan S, Saguner AM, Duru F, Koskenvuo JW, Cruz Marino T, Tichnell C, Judge DP, Dooijes D, Lekanne Deprez RH, Basso C, Pilichou K, Bauce B, Wilde AAM, Charron P, Fressart V, van der Heijden JF, van den Berg MP, Asselbergs FW, James CA, Jongbloed JDH, Harakalova M, van Tintelen JP

Citation: J Cardiovasc Transl Res. 2023 Jul 7. doi: 10.1007/s12265-023-10403-8. Online ahead of print.

Specialties: Cardiology, Cardiovascular disease, Endocrinology, Genetics

Disclaimer: One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
ESC EORP Cardiomyopathy Registry real life practice of genetic
Publication
The junctophilin-2 mutation p.(Thr161Lys) is associated with hypertrophic cardiomyopathy using patient-specific iPS cardiomyocytes and demonstrates prolonged action potential and increased arrhythmogenicity
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.